Literature DB >> 20601078

Fine mapping and interaction analysis of a linear rabies virus neutralizing epitope.

Kun Cai1, Jian-nan Feng, Qin Wang, Tao Li, Jing Shi, Xiao-jun Hou, Xiang Gao, Hao Liu, Wei Tu, Le Xiao, Hui Wang.   

Abstract

A novel human antibody AR16, targeting the G5 linear epitope of rabies virus glycoprotein (RVG) was shown to have promising antivirus potency. Using AR16, the minimal binding region within G5 was identified as HDFR (residues 261-264), with key residues HDF (residues 261-263) identified by alanine replacement scanning. The key HDF was highly conserved within phylogroup I Lyssaviruses but not those in phylogroup II. Using computer-aided docking and interaction models, not only the key residues (Asp30, Asp31, Tyr32, Trp53, Asn54, Glu99, Ile101, and Trp166) of AR16 that participated in the interaction with G5 were identified, the van der Waals forces that mediated the epitope-antibody interaction were also revealed. Seven out of eight presumed key residues (Asp30, Asp31, Tyr32, Trp53, Asn54, Glu99, and Ile101) were located at the variable regions of AR16 heavy chains. A novel mAb cocktail containing AR16 and CR57, has the potential to recognize non-overlapping, non-competing epitopes, and neutralize a broad range of rabies virus.
Copyright © 2010 Institut Pasteur. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601078     DOI: 10.1016/j.micinf.2010.06.005

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  4 in total

1.  Analysis of the evolution, infectivity and antigenicity of circulating rabies virus strains.

Authors:  Meina Cai; Haizhou Liu; Fei Jiang; Yeqing Sun; Wenbo Wang; Yimeng An; Mengyi Zhang; Xueli Li; Di Liu; Yuhua Li; Yongxin Yu; Weijin Huang; Youchun Wang
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

2.  Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies.

Authors:  Yange Niu; Ye Liu; Limin Yang; Hongren Qu; Jingyi Zhao; Rongliang Hu; Jing Li; Wenjun Liu
Journal:  Virol Sin       Date:  2016-04-06       Impact factor: 4.327

3.  Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups.

Authors:  Christine R Fisher; David E Lowe; Todd G Smith; Yong Yang; Christina L Hutson; Christoph Wirblich; Gino Cingolani; Matthias J Schnell
Journal:  Cell Rep       Date:  2020-07-21       Impact factor: 9.423

4.  Origins of the arctic fox variant rabies viruses responsible for recent cases of the disease in southern Ontario.

Authors:  Susan A Nadin-Davis; Christine Fehlner-Gardiner
Journal:  PLoS Negl Trop Dis       Date:  2019-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.